These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11917236)

  • 1. Comparative analysis of HIV-1 viral load assays on subtype quantification: Bayer Versant HIV-1 RNA 3.0 versus Roche Amplicor HIV-1 Monitor version 1.5.
    Elbeik T; Alvord WG; Trichavaroj R; de Souza M; Dewar R; Brown A; Chernoff D; Michael NL; Nassos P; Hadley K; Ng VL
    J Acquir Immune Defic Syndr; 2002 Apr; 29(4):330-9. PubMed ID: 11917236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma.
    Murphy DG; Côté L; Fauvel M; René P; Vincelette J
    J Clin Microbiol; 2000 Nov; 38(11):4034-41. PubMed ID: 11060065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of the Cobas Amplicor HIV-1 Monitor Ultrasensitive Test, the new Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test and the Versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samples.
    Berger A; Scherzed L; Stürmer M; Preiser W; Doerr HW; Rabenau HF
    J Clin Virol; 2005 May; 33(1):43-51. PubMed ID: 15797364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5.
    Elbeik T; Charlebois E; Nassos P; Kahn J; Hecht FM; Yajko D; Ng V; Hadley K
    J Clin Microbiol; 2000 Mar; 38(3):1113-20. PubMed ID: 10699005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative performance of three viral load assays on human immunodeficiency virus type 1 (HIV-1) isolates representing group M (subtypes A to G) and group O: LCx HIV RNA quantitative, AMPLICOR HIV-1 MONITOR version 1.5, and Quantiplex HIV-1 RNA version 3.0.
    Swanson P; Soriano V; Devare SG; Hackett J
    J Clin Microbiol; 2001 Mar; 39(3):862-70. PubMed ID: 11230396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of performance across the dynamic range of the Abbott RealTime HIV-1 assay as compared to VERSANT HIV-1 RNA 3.0 and AMPLICOR HIV-1 MONITOR v1.5 using serial dilutions of 39 group M and O viruses.
    Swanson P; Huang S; Abravaya K; de Mendoza C; Soriano V; Devare SG; Hackett J
    J Virol Methods; 2007 Apr; 141(1):49-57. PubMed ID: 17184853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive comparison of the VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 MONITOR 1.5 assays on 1,000 clinical specimens.
    Galli R; Merrick L; Friesenhahn M; Ziermann R
    J Clin Virol; 2005 Dec; 34(4):245-52. PubMed ID: 16286047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of HIV-1 genetic diversity on plasma HIV-1 RNA Quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test.
    Rouet F; Chaix ML; Nerrienet E; Ngo-Giang-Huong N; Plantier JC; Burgard M; Peeters M; Damond F; Ekouevi DK; Msellati P; Ferradini L; Rukobo S; Maréchal V; Schvachsa N; Wakrim L; Rafalimanana C; Rakotoambinina B; Viard JP; Seigneurin JM; Rouzioux C
    J Acquir Immune Defic Syndr; 2007 Aug; 45(4):380-8. PubMed ID: 17468666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of three commercial assays for the quantification of HIV-1 RNA in plasma from individuals infected with different HIV-1 subtypes.
    Chew CB; Herring BL; Zheng F; Browne C; Saksena NK; Cunningham AL; Dwyer DE
    J Clin Virol; 1999 Oct; 14(2):87-94. PubMed ID: 10588451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of the QUANTIPLEX HIV-1 RNA 2.0 and 3.0 (bDNA) assays and the AMPLICOR HIV-1 MONITOR v1.5 test for the quantitation of human immunodeficiency virus type 1 RNA in plasma.
    Anastassopoulou CG; Touloumi G; Katsoulidou A; Hatzitheodorou H; Pappa M; Paraskevis D; Lazanas M; Gargalianos P; Hatzakis A
    J Virol Methods; 2001 Jan; 91(1):67-74. PubMed ID: 11164487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rates of and reasons for failure of commercial human immunodeficiency virus type 1 viral load assays in Brazil.
    Drexler JF; de Souza Luna LK; Pedroso C; Pedral-Sampaio DB; Queiroz AT; Brites C; Netto EM; Drosten C
    J Clin Microbiol; 2007 Jun; 45(6):2061-3. PubMed ID: 17392448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test and identification of rare polymorphisms potentially affecting assay performance.
    Pyne MT; Brown KL; Hillyard DR
    J Clin Microbiol; 2010 Aug; 48(8):2852-8. PubMed ID: 20573864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of NucliSens HIV-1 EasyQ Version 2.0 compared with six commercially available quantitative nucleic acid assays for detection of HIV-1 in China.
    Xu S; Song A; Nie J; Li X; Wang Y
    Mol Diagn Ther; 2010 Oct; 14(5):305-16. PubMed ID: 21053996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Underevaluation of HIV-1 plasma viral load by a commercially available assay in a cluster of patients infected with HIV-1 A/G circulating recombinant form (CRF02).
    Amendola A; Bordi L; Angeletti C; Visco-Comandini U; Abbate I; Cappiello G; Budabbus MA; Eljhawi OA; Mehabresh MI; Girardi E; Antinori A; Ippolito G; Capobianchi MR
    J Acquir Immune Defic Syndr; 2002 Dec; 31(5):488-94. PubMed ID: 12473837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya.
    Emery S; Bodrug S; Richardson BA; Giachetti C; Bott MA; Panteleeff D; Jagodzinski LL; Michael NL; Nduati R; Bwayo J; Kreiss JK; Overbaugh J
    J Clin Microbiol; 2000 Jul; 38(7):2688-95. PubMed ID: 10878065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of three different commercial methods for measuring plasma viraemia in patients infected with non-B HIV-1 subtypes.
    Holguín A; de Mendoza C; Soriano V
    Eur J Clin Microbiol Infect Dis; 1999 Apr; 18(4):256-9. PubMed ID: 10385013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical comparison of an enhanced-sensitivity branched-DNA assay and reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma.
    Nolte FS; Boysza J; Thurmond C; Clark WS; Lennox JL
    J Clin Microbiol; 1998 Mar; 36(3):716-20. PubMed ID: 9508301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of human immunodeficiency virus viral load testing in Australia.
    Best SJ; Gust AP; Johnson EI; McGavin CH; Dax EM
    J Clin Microbiol; 2000 Nov; 38(11):4015-20. PubMed ID: 11060062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using RT-PCR and bDNA assays to measure non-clade B HIV-1 subtype RNA.
    Pasquier C; Sandres K; Salama G; Puel J; Izopet J
    J Virol Methods; 1999 Aug; 81(1-2):123-9. PubMed ID: 10488770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter study of the LCx HIV RNA quantitative assay--a new competitive reverse transcriptase-PCR which targets pol genomic region of HIV-1 for the measurement of type B, non-type B and group O HIV-1 RNA.
    Troonen H; Grey H; Michel G
    Clin Chem Lab Med; 2002 Jul; 40(7):698-704. PubMed ID: 12241017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.